2024
Early Release - Public Health Impact of Paxlovid as Treatment for COVID-19, United States - Volume 30, Number 2—February 2024 - Emerging Infectious Diseases journal - CDC
Bai Y, Du Z, Wang L, Lau E, Fung I, Holme P, Cowling B, Galvani A, Krug R, Meyers L. Early Release - Public Health Impact of Paxlovid as Treatment for COVID-19, United States - Volume 30, Number 2—February 2024 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2024, 30: 262-269. PMID: 38181800, PMCID: PMC10826746, DOI: 10.3201/eid3002.230835.Peer-Reviewed Original ResearchPlateauing atrial fibrillation burden in acute ischemic stroke admissions in the United States from 2010 to 2020
Otite F, Patel S, Aneni E, Lamikanra O, Wee C, Albright K, Burke D, Latorre J, Morris N, Anikpezie N, Singla A, Sonig A, Kamel H, Khandelwal P, Chaturvedi S. Plateauing atrial fibrillation burden in acute ischemic stroke admissions in the United States from 2010 to 2020. International Journal Of Stroke 2024, 19: 547-558. PMID: 38086764, DOI: 10.1177/17474930231222163.Peer-Reviewed Original ResearchAtrial fibrillationAIS hospitalizationsAF prevalenceJoinpoint regressionSerial cross-sectional studyAcute ischemic stroke admissionsStudy periodComorbid atrial fibrillationIschemic stroke preventionAtrial fibrillation burdenIschemic stroke admissionsSex-standardized prevalenceNational Inpatient SampleCross-sectional studySimilar aged menAge/sex groupsMen 40Stroke preventionOral anticoagulantsStroke admissionsWomen 40Inpatient SampleDiseases codesMen 18Hospitalization
2023
Is hospitalization a missed opportunity to intervene on tobacco cessation?
Nielsen E, Zhang J, Marsden J, Bays C, Moran W, Mauldin P, Lenert L, Toll B, Schreiner A, Heincelman M. Is hospitalization a missed opportunity to intervene on tobacco cessation? The American Journal Of The Medical Sciences 2023, 367: 89-94. PMID: 38043793, DOI: 10.1016/j.amjms.2023.11.024.Peer-Reviewed Original ResearchTobacco cessationNRT prescriptionCurrent smokersTobacco usePatient-centered medical homeStudy periodNicotine replacement therapy productsRetrospective cohort studyPrimary care physiciansLogistic regression modelsProportion of adultsHealth-related changesAdult patientsCohort studyHospital dischargeMost patientsCare physiciansElevated morbidityMedical homeHospitalizationSmokersPatientsCessationPrescriptionTeachable momentHospital Admissions for Abusive Head Trauma Before and During the COVID-19 Pandemic
Maassel N, Graetz E, Schneider E, Asnes A, Solomon D, Leventhal J. Hospital Admissions for Abusive Head Trauma Before and During the COVID-19 Pandemic. JAMA Pediatrics 2023, 177: 1342-1347. PMID: 37870839, PMCID: PMC10594171, DOI: 10.1001/jamapediatrics.2023.4519.Peer-Reviewed Original ResearchConceptsAbusive head traumaCross-sectional studyMonthly hospitalizationsHead traumaClinical characteristicsSignificant decreaseCOVID-19 pandemicPediatric Health Information SystemTertiary care children's hospitalMean monthly incidenceClinical Modification codesHospitalization of childrenInterrupted time series analysisCOVID-19Subgroup of childrenHospital admissionChildren's HospitalTenth RevisionHospitalizationMAIN OUTCOMEInternational ClassificationSevere formCOVID-19 periodHealth information systemsPreventive efforts1368. In-hospital and post-discharge mortality among adults with COVID-19 associated hospitalization, COVID-NET, March 2020–April 2021.
Patel K, Kirley P, Kawasaki B, Meek J, Openo K, Monroe M, Henderson J, Lynfield R, Sosin D, Rowe A, Bushey S, Shiltz E, Sutton M, Talbot H, Swain A, Whitaker M, Taylor C, Havers F. 1368. In-hospital and post-discharge mortality among adults with COVID-19 associated hospitalization, COVID-NET, March 2020–April 2021. Open Forum Infectious Diseases 2023, 10: ofad500.1205. PMCID: PMC10677354, DOI: 10.1093/ofid/ofad500.1205.Peer-Reviewed Original ResearchCOVID-19-Associated Hospitalization Surveillance NetworkPost-discharge mortalityCOVID-19-associated hospitalizationLaboratory-confirmed COVID-19Hospitalization ratesHospital mortalityChart reviewAdult ageLaboratory-confirmed COVID-19-associated hospitalizationsCOVID-19Positive SARS-CoV-2 testAge groupsPopulation-based surveillance systemSARS-CoV-2 testSurveillance networkDetailed chart reviewFull chart reviewDeath certificate dataProportion of mortalityHospital dischargeCase definitionCertificate dataHospitalizationHospitalMortality2618. Four Respiratory Viruses are Involved in the Majority of Community-Acquired Alveolar Pneumonia (CAAP) Episodes in Children < 5 Years
Dagan R, van der Beek B, Greenberg D, Ben-Shimol S, Keren-Naos A, Weinberger D, Danino D. 2618. Four Respiratory Viruses are Involved in the Majority of Community-Acquired Alveolar Pneumonia (CAAP) Episodes in Children < 5 Years. Open Forum Infectious Diseases 2023, 10: ofad500.2231. PMCID: PMC10679033, DOI: 10.1093/ofid/ofad500.2231.Peer-Reviewed Original ResearchAlveolar pneumoniaRespiratory virusesBacterial-viral coinfectionsOnly medical centerProspective active surveillanceYoung childrenGrant/research supportParainfluenza virusActive surveillanceMedical CenterNasal samplesHospitalizationPositive specimensEpidemiological activityViral detectionStudy periodViral activityMonthly incidenceMultiple studiesVirusPneumoniaChildrenEpisodesMain virusesRSVFalls prechemotherapy and toxicity‐related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial
Ji J, Bae M, Sun C, Wildes T, Freedman R, Magnuson A, O'Connor T, Moy B, Klepin H, Chapman A, Tew W, Dotan E, Fenton M, Kim H, Katheria V, Gross C, Cohen H, Muss H, Sedrak M. Falls prechemotherapy and toxicity‐related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial. Cancer 2023, 130: 936-946. PMID: 37962093, PMCID: PMC10922500, DOI: 10.1002/cncr.35105.Peer-Reviewed Original ResearchToxicity-related hospitalizationAdjuvant chemotherapyBreast cancerOlder womenPrimary end pointEarly breast cancerMultivariable logistic regressionGeriatric characteristicsGeriatric covariatesHOPE trialIncident hospitalizationGeriatric assessmentProspective studyGeriatric factorsHospitalizationChemotherapyGreater oddsStage IOlder personsEnd pointCancerLogistic regressionCategorical variablesWomenDiseaseComparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults
Kopel H, Nguyen V, Boileau C, Bogdanov A, Winer I, Ducruet T, Zeng N, Bonafede M, Esposito D, Martin D, Rosen A, Van de Velde N, Vermund S, Gravenstein S, Mansi J. Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults. Vaccines 2023, 11: 1711. PMID: 38006043, PMCID: PMC10675676, DOI: 10.3390/vaccines11111711.Peer-Reviewed Original ResearchCOVID-19-related hospitalizationRelative vaccine effectivenessOutpatient visitsPrimary care electronic health recordsCOVID-19-related outcomesVaccine-induced protectionMedical claims dataCOVID-19 vaccineSARS-CoV-2Electronic health recordsVaccine effectivenessVaccine recipientsMRNA vaccinesBivalent vaccineBaseline differencesStudy populationClaims dataOmicron variantComparative effectivenessHospitalizationPropensity scoreVaccineOlder adultsHealth recordsVisitsEffect of dapagliflozin on outpatient worsening heart failure in patients with mildly reduced or preserved ejection fraction: the DELIVER trial
Chatur S, Vaduganathan M, Claggett B, Desai A, Docherty K, Jhund P, De Boer R, Hernandez A, Inzucchi S, Kosiborod M, Lam C, Martinez F, Shah S, Mcmurray J, Solomon S. Effect of dapagliflozin on outpatient worsening heart failure in patients with mildly reduced or preserved ejection fraction: the DELIVER trial. European Heart Journal 2023, 44: ehad655.751. DOI: 10.1093/eurheartj/ehad655.751.Peer-Reviewed Original ResearchUrgent HF visitsHeart failureHF eventsHF hospitalizationHF visitsEjection fractionFirst presentationSubsequent mortalityComposite endpointSubsequent deathEffect of dapagliflozinTreatment effectsBackground HospitalizationCV causesCV deathDose uptitrationPrimary endpointPrognostic importanceClinical trialsFirst manifestationLandmark analysisAmbulatory careHospitalizationClinical relevancePatientsImpact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network
Udelsman B, Detterbeck F, Tanoue L, Mase V, Boffa D, Blasberg J, Dhanasopon A, Ely S, Mazzarelli L, Bader A, Woodard G. Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network. Journal Of Computer Assisted Tomography 2023, 48: 222-225. PMID: 37832536, DOI: 10.1097/rct.0000000000001549.Peer-Reviewed Original ResearchHealth care networkLung cancer screening processLung cancer screening programsCare networkCancer screening programsCoronavirus disease 2019 (COVID-19) pandemicComputed tomography scanCOVID-19 hospitalizationCOVID-19 surgeCancer screening processDisease 2019 pandemicLung cancer diagnosisHealth care systemAverage hospitalizationRadiology databaseLung cancerTomography scanScreening programCare systemCancer diagnosisMonthsHospitalizationCOVID-19COVID-19 pandemicPandemicSystematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials
Smith A, DiMartino L, Garcia S, Mitchell S, Ruddy K, Smith J, Wong S, Cahue S, Cella D, Jensen R, Hassett M, Hodgdon C, Kroner B, Osarogiagbon R, Popovic J, Richardson K, Schrag D, Cheville A, Cella D, Cheville A, Hassett M, Osarogiagbon R, Schrag D, Wong S, Kroner B, Smith A, DiMartino L, Garcia S, Griffin J, Jensen R, Mitchell S, Ruddy K, Smith J, Yanez B, Bian J, Dizon D, Hazard-Jenkins H, Ardini M, Ahrens P, Austin J, Barrett F, Bass M, Begnoche M, Cahue S, Caron K, Chlan L, Coughlin A, Cronin C, Dias S, Farisiv N, Flores A, Garcia M, Hemming K, Herrin J, Hodgdon C, Kircher S, Kroenke K, Lam V, Lancki N, H Q, Mallow J, McCleary N, Norton W, O'Connor M, Pachman D, Pearsonil L, Penedo F, Podratz J, Popovic J, Preiss L, Rahman P, Redmond S, Reich J, Richardson J, Richardson K, Ridgeway J, Rutten L, Schaepe K, Scholtens D, Poirier-Shelton T, Silberman P, Simpson J, Tasker L, Tesch N, Tofthagen C, Tramontano A, Tyndall B, Uno H, Wehbe F, Weiner B. Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials. JNCI Cancer Spectrum 2023, 7: pkad073. PMID: 37930033, PMCID: PMC10627528, DOI: 10.1093/jncics/pkad073.Peer-Reviewed Original ResearchConceptsSymptom management systemManagement of symptomsEffectiveness-implementation trialPhases of careHealth care needsElectronic health record platformsQuality of lifeHealth record platformsSymptom managementImplementation trialHealthcare needsTreatment ConsortiumStudy designSymptomsDeleterious symptomsHybrid effectivenessRecord platformCOVID-19 pandemicContext of disruptionTrialsHospitalizationCancerCareDaily Summer Temperatures and Hospitalization for Acute Cardiovascular Events: Impact of Outdoor PM2.5 Oxidative Potential on Observed Associations Across Canada
Weichenthal S, Lavigne E, You H, Pollitt K, Shin T, Kulka R, Stieb D, Hatzopoulou M, Evans G, Burnett R. Daily Summer Temperatures and Hospitalization for Acute Cardiovascular Events: Impact of Outdoor PM2.5 Oxidative Potential on Observed Associations Across Canada. Epidemiology 2023, 34: 897-905. PMID: 37732880, DOI: 10.1097/ede.0000000000001651.Peer-Reviewed Original ResearchConceptsIschaemic heart disease eventsHeart disease eventsAcute cardiovascular eventsCardiovascular eventsDisease eventsOdds ratioPotential time-varying confoundersAcute cardiovascular effectsFine particulate air pollutionCase-crossover studyOutdoor fine particulate air pollutionHealth impactsCardiovascular health impactsParticulate air pollutionCardiovascular effectsHighest tertileTime-varying confoundersOlder subjectsHospitalizationObserved associationsOxidative stressOxidative potentialPM2.5 oxidative potentialMonthsAssociationThe effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service
Ferrara M, Guloksuz S, Hazan H, Li F, Tek C, Sykes L, Riley S, Keshavan M, Srihari V. The effect of duration of untreated psychosis (DUP) on the risk for hospitalization after admission to a first episode service. Schizophrenia Research 2023, 260: 198-204. PMID: 37688984, DOI: 10.1016/j.schres.2023.08.005.Peer-Reviewed Original ResearchConceptsFirst-episode psychosis servicesLength of stayUntreated psychosisPsychiatric hospitalizationFirst-episode servicesDuration of hospitalizationIncidence rate ratiosNon-affective psychosisNew Haven areaPoisson regression modelsPatient characteristicsHospitalization ratesRecent onsetMedical recordsHospitalizationEffect of durationNegative binomial regressionSpecialized treatmentPsychosisRate ratioBinomial regressionAdmissionDUPEnrollmentFirst yearHospitalization Trends and Outcomes of Eosinophilic Esophagitis in the United States: A Decade-Long Nationwide Analysis
Kwei-Nsoro R, Ojemolon P, Attar B, Shaka H, Zarza-Gulino P, Asare M, Annor E, Mba B. Hospitalization Trends and Outcomes of Eosinophilic Esophagitis in the United States: A Decade-Long Nationwide Analysis. Cureus 2023, 15: e44315. PMID: 37779798, PMCID: PMC10536399, DOI: 10.7759/cureus.44315.Peer-Reviewed Original ResearchTotal hospital chargesNational Inpatient SampleLength of stayJoinpoint regression analysisPrevalence ratesEosinophilic esophagitisHospitalization trendsStudy periodMortality ratePrevalence of EoEInflammatory bowel diseaseAnnual percentage changeAverage prevalence rateRegression analysisHospital-specific variablesPatient demographicsBowel diseaseHospital chargesInpatient DatabaseInpatient SampleMale genderEsophageal mucosaEsophageal diseaseHospitalizationNationwide analysisOutpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial
Chatur S, Vaduganathan M, Claggett B, Cunningham J, Docherty K, Desai A, Jhund P, de Boer R, Hernandez A, Inzucchi S, Kosiborod M, Lam C, Martinez F, Shah S, Petersson M, Langkilde A, McMurray J, Solomon S. Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial. Circulation 2023, 148: 1735-1745. PMID: 37632455, PMCID: PMC10664793, DOI: 10.1161/circulationaha.123.066506.Peer-Reviewed Original ResearchConceptsUrgent HF visitsComposite end pointHeart failureHF hospitalizationHF visitsHF eventsFirst presentationCardiovascular deathEnd pointEjection fractionSubsequent mortalitySubsequent deathEjection fraction heart failurePrimary end pointCardiovascular causesClinical decompensationPrespecified analysisAmbulatory carePatientsClinical relevanceSentinel eventsHospitalizationDapagliflozinDeathVisitsDemographic Disparities in the Incidence, Clinical Characteristics, and Outcome of Posterior Reversible Encephalopathy Syndrome in the United States
Otite F, Patel S, Anikpezie N, Hoffman H, Beutler T, Akano E, Aneni E, Lamikanra O, Osondu C, Wee C, Burke D, Albright K, Latorre J, Mejico L, Khandelwal P, Chaturvedi S. Demographic Disparities in the Incidence, Clinical Characteristics, and Outcome of Posterior Reversible Encephalopathy Syndrome in the United States. Neurology 2023, 101: e1554-e1559. PMID: 37487751, PMCID: PMC10585693, DOI: 10.1212/wnl.0000000000207604.Peer-Reviewed Original ResearchConceptsPosterior reversible encephalopathy syndromeNational Readmission DatabaseReversible encephalopathy syndromeEncephalopathy syndromeFemale patientsHispanic patientsMale patientsSex-standardized incidenceRetrospective cohort studyRace-specific incidenceSimilar demographic distributionState Inpatient DatabasesNon-Hispanic whitesIncident hospitalizationClinical characteristicsCohort studyFirst hospitalizationBlack patientsInpatient DatabasePatientsNew casesIncidenceStudy periodDemographic disparitiesHospitalizationYear-Round Respiratory Syncytial Virus Transmission in The Netherlands Following the COVID-19 Pandemic: A Prospective Nationwide Observational and Modeling Study
Löwensteyn Y, Zheng Z, Rave N, Bannier M, Billard M, Casalegno J, Pitzer V, Wildenbeest J, Weinberger D, Bont L, Putten M, Smit-Kleinlugtenbeld E, Peetsold M, van der Kuip M, van Goudoever H, van Keulen B, Boot A, Kloos R, van Gool S, Snepvangers Y, Kuijpers A, Menelik N, de Crom S, Miedema C, Tusscher G, van Giessen J, de Moor R, Faber M, Breukels M, Jaddoe V, Duijts L, Lutterman C, Vink I, Tramper-Stranders G, Oudshoorn A, Ritman A, Dubbink-Verheij G, Bolt J, Cakir C, Rietveld E, Bekhof J, Rings E, de Swart J, Driessen G, Doedens R, Nijssen L, van Onzenoort-Bokken L, Meijneke R, van Scherpenzeel M, Faber T, de Groof F, Schouten S, van de Zande J, de Coul M, Henriet S, Stol K, van Rossem M, Jacobs M, van Houten M, Zuurbier R, Plötz F, de Vries A, van der Heide R, van Boekholt A, de Jong G, Rashid A, Roelofs M, Illy K, Reijmerink N, van Dorth S, Schipper S, Rosias P, Teirlinck A. Year-Round Respiratory Syncytial Virus Transmission in The Netherlands Following the COVID-19 Pandemic: A Prospective Nationwide Observational and Modeling Study. The Journal Of Infectious Diseases 2023, 228: 1394-1399. PMID: 37477906, PMCID: PMC10640768, DOI: 10.1093/infdis/jiad282.Peer-Reviewed Original ResearchResponse to substance use during hospitalization: A survey study of current and ideal policies and practices
Huxley‐Reicher Z, Puglisi L, Tetrault J, Weimer M, Stellini M, Bhandary‐Alexander J, Thomas K, Donroe J. Response to substance use during hospitalization: A survey study of current and ideal policies and practices. Journal Of Hospital Medicine 2023, 18: 829-834. PMID: 37475186, DOI: 10.1002/jhm.13162.Peer-Reviewed Original ResearchHospital policiesAddiction medicine fellowshipsPatient-directed dischargeSubstance useCross-sectional studyWorse patient outcomesMajority of hospitalsAcute hospitalizationPatient outcomesUse of substancesPatient-centered policiesHospitalizationUS hospitalsLittle dataGraduate Medical EducationHospitalCliniciansAccreditation CouncilSurvey studyResponseCurrent practiceSevere hypoglycemia and falls in older adults with diabetes: The Diabetes & Aging Study
Moffet H, Huang E, Liu J, Parker M, Lipska K, Laiteerapong N, Grant R, Lee A, Karter A. Severe hypoglycemia and falls in older adults with diabetes: The Diabetes & Aging Study. Diabetes Epidemiology And Management 2023, 12: 100162. PMID: 37920602, PMCID: PMC10621321, DOI: 10.1016/j.deman.2023.100162.Peer-Reviewed Original ResearchSevere hypoglycemiaOlder adultsRisk of fallsCare-seeking behaviorLife-threatening eventsED visitsInpatient recordsPrevalence ratiosHypoglycemiaGreater prevalenceAge 65Clinical documentationDiabetesSample adultsAging StudyAdultsSurvey respondentsFallHospitalizationOutpatientsResearch designPrevalenceVisitsMonthsSeverityEditorial: Developmental considerations in addressing the earlier age of severe eating disorder onset
Kamody R, Bloch M. Editorial: Developmental considerations in addressing the earlier age of severe eating disorder onset. Journal Of Child Psychology And Psychiatry 2023, 64: 1101-1103. PMID: 37408467, DOI: 10.1111/jcpp.13852.Peer-Reviewed Original ResearchConceptsMental health concernsHealth concernYouth mental health careMental health careCOVID-19 pandemicImpact of ageYouth mental healthSevere presentationPediatric hospitalizationsDisorder onsetAge of childrenDisorder presentationsMental healthHealth careHospitalizationAgeEarly ageCareDisordersDevelopmental considerationsOnsetPresentationPandemicDeleterious impact
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply